Skip to main content

Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001658247

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CRNX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8083+3
Shares30.7M32.9M+2.14M (+7.0%)
Value$465.3M$616.9M+$151.7M (+32.6%)

New holders (12)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CRNX in Q2 2021
InstitutionSharesValue% of portfolio
Ghost Tree Capital, LLC243,309$4.59M1.43%
Caas Capital Management LP166,317$3.13M0.17%
Citadel Advisors LLC60,658$1.14M0.00%
Marshall Wace North America L.P.43,671$824.0K0.00%
D. E. Shaw & Co., Inc.31,232$589.0K0.00%
BVF Inc24,280$458.0K0.02%
Schonfeld Strategic Advisors LLC21,800$411.0K0.00%
Invesco Ltd.13,702$258.0K0.00%
Great West Life Assurance Co1,457$27.0K0.00%
Quantbot Technologies LP700$13.0K0.00%
TCI Wealth Advisors, Inc.118$2.00K0.00%
State of Wyoming52$1.00K0.00%

Sold out (9)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CRNX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Novo Holdings A/S271,378$4.15M
Eventide Asset Management, LLC241,140$3.69M
California Public Employees Retirement System54,800$837.0K
Russell Investments Group, Ltd.14,001$213.0K
Wells Fargo & Company5,195$79.0K
UBS Group AG4,129$63.0K
Bank of Montreal731$13.0K
Panagora Asset Management Inc324$5.00K
Ameritas Investment Company, LLC300$4.58K